These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The DIMOND project and its impact on radiation protection. Faulkner K Radiat Prot Dosimetry; 2005; 117(1-3):3-6. PubMed ID: 16461511 [TBL] [Abstract][Full Text] [Related]
9. Coordination of research on internal dosimetry in Europe: the CONRAD project. Lopez MA; Etherington G; Castellani CM; Franck D; Hurtgen C; Marsh JW; Nosske D; Doerfel H; Andrasi A; Bailey M; Balashazy I; Battisti P; Bérard P; Berkowski V; Birchall A; Blanchardon E; Bonchuk Y; de Carlan L; Cantone MC; Challeton-de Vathaire C; Cruz-Suarez R; Davis K; Dorrian D; Giussani A; Le Guen B; Hodgson A; Jourdain JR; Koukouliou V; Luciani A; Malatova I; Molokanov A; Moraleda M; Muikku M; Oeh U; Puncher M; Rahola T; Ratia H; Stradling N Radiat Prot Dosimetry; 2007; 127(1-4):311-6. PubMed ID: 17686965 [TBL] [Abstract][Full Text] [Related]
10. FDA IND approval for Zn-DTPA, new clinical agent for decorporation therapy of actinides. Lushbaugh CC; Washburn LC J Nucl Med; 1979 Jan; 20(1):73. PubMed ID: 219167 [No Abstract] [Full Text] [Related]
11. Assessment of actinide decay data evaluations: findings of an IAEA Coordinated Research Project. Kellett MA Appl Radiat Isot; 2012 Sep; 70(9):1919-23. PubMed ID: 22425418 [TBL] [Abstract][Full Text] [Related]
12. Study of the U/Am separation with supported calix[6]arene in the aim of urinary actinides analysis. Poriel L; Boulet B; Cossonnet C; Bouvier-Capely C Radiat Prot Dosimetry; 2007; 127(1-4):273-6. PubMed ID: 17562653 [TBL] [Abstract][Full Text] [Related]
13. Actinide chelation: biodistribution and in vivo complex stability of the targeted metal ions. Kullgren B; Jarvis EE; An DD; Abergel RJ Toxicol Mech Methods; 2013 Jan; 23(1):18-26. PubMed ID: 22957518 [TBL] [Abstract][Full Text] [Related]
14. FDA IND approval for Zn-DTPA, new clinical agent for decorporation therapy of actinides. Lushbaugh CC; Washburn LC Health Phys; 1979 Mar; 36(3):472. PubMed ID: 226499 [No Abstract] [Full Text] [Related]
15. MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapy. Fritsch P; Grémy O; Hurtgen C; Bérard P; Grappin L; Poncy JL Radiat Prot Dosimetry; 2011 Mar; 144(1-4):371-5. PubMed ID: 21131659 [TBL] [Abstract][Full Text] [Related]
16. Lauriston S. Taylor Lecture: the quest for therapeutic actinide chelators. Durbin PW Health Phys; 2008 Nov; 95(5):465-92. PubMed ID: 18849679 [TBL] [Abstract][Full Text] [Related]
17. Uncertainties in estimation of intakes of actinides for dose reconstruction cases. Wilson G; Bull RK Radiat Prot Dosimetry; 2007; 127(1-4):563-8. PubMed ID: 17634206 [TBL] [Abstract][Full Text] [Related]
18. Surface-seeking radionuclides in the skeleton: current approach and recent developments in biokinetic modelling for humans and beagles. Luciani A; Polig E Radiat Prot Dosimetry; 2007; 127(1-4):140-3. PubMed ID: 17562648 [TBL] [Abstract][Full Text] [Related]